Medication adherence by patients with chronic heart failure
Rebecca Ireland
This article has no abstract so we have provided the first paragraph of the full text.
Medications and lifestyle alterations have been shown to reduce mortality in patients with chronic heart failure (CHF), but patients do not always adhere to such recommendations. Granger et al. used CHARM, a multicenter, randomized, placebo-controlled study that compared candesartan (an angiotensin-receptor blocker) with placebo in CHF patients, to investigate the association between adherence to medication and mortality in these patients.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Phage display extends its reachNature Biotechnology News and Views (01 Jul 2006)
Obituary John Backus (1924?2007)Nature News and Views (26 Apr 2007)
